These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11885549)

  • 1. Laboratory-confirmed reinfections with Bordetella pertussis.
    Versteegh FG; Schellekens JF; Nagelkerke AF; Roord JJ
    Acta Paediatr; 2002; 91(1):95-7. PubMed ID: 11885549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pertussis resurgence among vaccinated children in Khairpur, Sindh, Pakistan.
    Mughal A; Kazi YF; Bukhari HA; Ali M
    Public Health; 2012 Jun; 126(6):518-22. PubMed ID: 22445714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiological situation of pertussis in the Federal Republic of Germany.
    Finger H; Wirsing von König CH; Tacken A; Wassilak SG
    Dev Biol Stand; 1991; 73():343-55. PubMed ID: 1778329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunologic findings in oral pertussis vaccination].
    Kurz R; Mayr J; Höfler KH; Falk W; Rosanelli K
    Padiatr Padol; 1986; 21(1):53-9. PubMed ID: 2870453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of Bordetella pertussis infection by culture, real-time polymerase chain reaction and serologic tests among children with prolonged cough].
    Gürsel D; Aslan A; Sönmez C; Koturoğlu G; Cöplü N; Kurugöl Z; Aydemir S
    Mikrobiyol Bul; 2012 Apr; 46(2):211-24. PubMed ID: 22639310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
    Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
    Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IgA antibody to Bordetella pertussis as an indicator of infection.
    Nagel J; Poot-Scholtens EJ
    J Med Microbiol; 1983 Nov; 16(4):417-26. PubMed ID: 6315942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whooping Cough in Adults: A Series of Severe Cases.
    Zycinska K; Cieplak M; Chmielewska M; Nitsch-Osuch A; Klaczkow A; Hadzik-Blaszczyk M; Kur Z; Wardyn KA
    Adv Exp Med Biol; 2017; 955():47-50. PubMed ID: 28039663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population.
    He Q; Viljanen MK; Arvilommi H; Aittanen B; Mertsola J
    JAMA; 1998 Aug; 280(7):635-7. PubMed ID: 9718056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Whooping cough: diagnosis, prevention].
    Ovetchkine P
    Rev Prat; 1999 May; 49(10):1107-13. PubMed ID: 10485198
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis of whooping cough: comparison of serological tests with isolation of Bordetella pertussis. A combined Scottish study.
    Br Med J; 1970 Dec; 4(5736):637-9. PubMed ID: 4321207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crucial role of antibodies to pertactin in Bordetella pertussis immunity.
    Hellwig SM; Rodriguez ME; Berbers GA; van de Winkel JG; Mooi FR
    J Infect Dis; 2003 Sep; 188(5):738-42. PubMed ID: 12934190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bordetella parapertussis infections.
    Mastrantonio P; Giuliano M; Stefanelli P; Sofia T; De Marzi L; Tarabini G; Quarto M; Moiraghi A
    Dev Biol Stand; 1997; 89():255-9. PubMed ID: 9272358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels.
    Nagel J; de Graaf S; Schijf-Evers D
    Dev Biol Stand; 1985; 61():325-30. PubMed ID: 2872120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of murine antibodies against whole-cell pertussis vaccine or filamentous haemagglutinin by Bordetella pertussis from patients with whooping cough.
    van den Berg BM; Beekhuizen H; Van Furth R; Mooi FR
    Scand J Immunol; 2000 May; 51(5):530-2. PubMed ID: 10792847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012.
    Bailon H; León-Janampa N; Padilla C; Hozbor D
    BMC Infect Dis; 2016 Aug; 16():422. PubMed ID: 27530444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bordetella pertussis infection in a child with completed primary immunization: A case report.
    Shankar AG; Lee A; Reddy H; Seymour M
    Hum Vaccin Immunother; 2013 Feb; 9(2):322-4. PubMed ID: 23291950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
    Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
    APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R; Lønnes T; Møgster B; Berdal BP
    Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.